Deterioration in Asthma Control When Subjects Receiving Fluticasone Propionate/Salmeterol 100/50 mcg Diskus are “Stepped-Down”

References

• National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD 2007, Expert Panel Report 3; NIH publication 08-4051
   Google Scholar
• Pauwels R A, Lofdahl C-G, Postma D S, Tattersfield A E, O'Byrne P, Barnes P J, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405–1411
   PubMed Web of Science ®Google Scholar
• Matz J, Emmett A, Rickard K, Kalberg C. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations. J Allergy Clin Immunol 2001; 107: 783–789
   PubMedGoogle Scholar
• Tattersfield A E, Postma D S, Barnes P J, Svensson K, Bauer C A, O'Byrne P M, Lofdahl C G, Pauwels R A, Ullman A. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999; 160: 594–599
   PubMed Web of Science ®Google Scholar
• Taylor D R, Town G I, Herbison G P, Boothman-Burrell D, Flannery E M, Hancox B, Harre E, Laubscher K, Linscott V, Ramsay C M, Richards G. Asthma control during long term treatment with regular inhaled salbutamol and salmeterol. Thorax 1998; 53: 744–752
   PubMed Web of Science ®Google Scholar
• Busse W, Koenig S M, Oppenheimer J, Sahn S A, Yancey S W, Reilly D, Edwards L D, Dorinsky P M. Steroid-sparing effects of fluticasone propionate 100 mcg and salmeterol 50 mcg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 mcg administered twice daily. J Allergy Clin Immunol 2003; 111: 57–65
   Google Scholar
• Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000; 105: 1108–1116
   PubMed Web of Science ®Google Scholar
• Shapiro G, Lumry W, Wolfe J, Given J, White M V, Woodring A, Baitinger L, House K, Prillaman B, Shah T. Combined salmeterol 50μ g and fluticasone propionate 250μ g in the Diskus device for the treatment of asthma. Am J Respir Crit Care Med 2000; 161: 527–534
   PubMed Web of Science ®Google Scholar
• Aubier M, Pieters W R, Schlosser N J, Steinmetz K O. Salmeterol/fluticasone propionate (50/50 μ g) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med 1999; 93: 876–884
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244
   PubMed Web of Science ®Google Scholar
• Nelson H S, Weiss S T, Bleecker E R, Yancey S W, Dorinsky P M. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129: 15–26
   PubMed Web of Science ®Google Scholar
• McIvor R A, Pizzichini C, Turner M O, Hussack P, Hargreave F E, Sears M R. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998; 158: 924–930
   PubMed Web of Science ®Google Scholar
• Lazarus S C, Boushey H A, Fahy J V, Chinchilli V M, Lemanske R F, Sorkness C A, Kraft M, Fish J E, Peters S P, Craig T, Drazen J M, Ford J G, Israel E, Martin R J, Mauger E A, Nachman S A, Spahn J D, Szefler S J. Long-acting beta2-agonist monotherapy vs. continued therapy with inhaled corticosteroids in patients with persistent asthma. JAMA 2001; 285: 2583–2593
   PubMed Web of Science ®Google Scholar
• Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei L X, Seidenberg B C, Reiss T F. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. Ann Intern Med 1999; 130: 487–495
   PubMed Web of Science ®Google Scholar
• Stoloff S W, Stempel D A, Meyer J, Stanford R H, Carranza Rosenzweig J. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004; 113: 245–251
   PubMed Web of Science ®Google Scholar
• Bateman E D, Britton M, Carrillo J, Almeida J, Wixon C. Salmeterol/Fluticasone Combination Inhaler: A New Effective and Well Tolerated Treatment for Asthma. Clin Drug Invest 1998; 16: 193–201
   PubMed Web of Science ®Google Scholar